Interactions between colon cancer cells and tumor-infiltrated macrophages depending on cancer cell-derived colony stimulating factor 1

References

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61:69-90; PMID:21296855; http://dx.doi.org/10.3322/caac.20107
   PubMed Web of Science ®Google Scholar
• Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin 2009; 59:366-78; PMID:19897840; http://dx.doi.org/10.3322/caac.20038
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Mochizuki H, Sugihara K, Morita T, Kotake K, Teramoto T, Kameoka S, Saito Y, Takahashi K, Hase K et al. Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study. Surgery 2007; 141:67-75; PMID:17188169; http://dx.doi.org/10.1016/j.surg.2006.07.020
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013
   PubMed Web of Science ®Google Scholar
• Fridman WH, Pages F, Sautes-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 2012; 12:298-306; PMID:22419253; http://dx.doi.org/10.1038/nrc3245
   PubMed Web of Science ®Google Scholar
• Solinas G, Germano G, Mantovani A, Allavena P. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukoc Biol 2009; 86:1065-73; PMID:19741157; http://dx.doi.org/10.1189/jlb.0609385
   PubMed Web of Science ®Google Scholar
• Forssell J, Oberg A, Henriksson ML, Stenling R, Jung A, Palmqvist R. High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin Cancer Res 2007; 13:1472-9; PMID:17332291; http://dx.doi.org/10.1158/1078-0432.CCR-06-2073
   PubMed Web of Science ®Google Scholar
• Etoh T, Shibuta K, Barnard GF, Kitano S, Mori M. Angiogenin expression in human colorectal cancer: the role of focal macrophage infiltration. Clin Cancer Res 2000; 6:3545-51; PMID:10999742
   PubMed Web of Science ®Google Scholar
• Hong F, Wu BX, Li Z. Molecular regulation of macrophages in unleashing cancer-related inflammation. Oncoimmunology 2014; 3:e27659; PMID:24778928; http://dx.doi.org/10.4161/onci.27659
   PubMedGoogle Scholar
• Chaput N, Svrcek M, Auperin A, Locher C, Drusch F, Malka D, Taieb J, Goere D, Ducreux M, Boige V. Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II-III colorectal cancer. Br J Cancer 2013; 109:1013-22; PMID:23868006; http://dx.doi.org/10.1038/bjc.2013.362
   PubMed Web of Science ®Google Scholar
• Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 2010; 141:39-51; PMID:20371344; http://dx.doi.org/10.1016/j.cell.2010.03.014
   PubMed Web of Science ®Google Scholar
• Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity 2014; 41:49-61; PMID:25035953; http://dx.doi.org/10.1016/j.immuni.2014.06.010
   PubMed Web of Science ®Google Scholar
• Smith HO, Anderson PS, Kuo DY, Goldberg GL, DeVictoria CL, Boocock CA, Jones JG, Runowicz CD, Stanley ER, Pollard JW. The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma. Clin Cancer Res 1995; 1:313-25; PMID:9815987
   PubMed Web of Science ®Google Scholar
• Behnes CL, Bremmer F, Hemmerlein B, Strauss A, Strobel P, Radzun HJ. Tumor-associated macrophages are involved in tumor progression in papillary renal cell carcinoma. Virchows Arch 2014; 464:191-6; PMID:24327306; http://dx.doi.org/10.1007/s00428-013-1523-0
   PubMed Web of Science ®Google Scholar
• Wyckoff JB, Wang Y, Lin EY, Li JF, Goswami S, Stanley ER, Segall JE, Pollard JW, Condeelis J. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res 2007; 67:2649-56; PMID:17363585; http://dx.doi.org/10.1158/0008-5472.CAN-06-1823
   PubMed Web of Science ®Google Scholar
• Liu H, Zhang Z, Tabuchi T, Wang S, Wang J. The role of pro-inflammatory cytokines and immune cells in colorectal carcinoma progression. Oncol Lett 2013; 5:1177-82; PMID:23599759
   PubMed Web of Science ®Google Scholar
• Hume DA, MacDonald KP. Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. Blood 2012; 119:1810-20; PMID:22186992; http://dx.doi.org/10.1182/blood-2011-09-379214
   PubMed Web of Science ®Google Scholar
• Jakubowski AA, Bajorin DF, Templeton MA, Chapman PB, Cody BV, Thaler H, Tao Y, Filippa DA, Williams L, Sherman ML et al. Phase I study of continuous-infusion recombinant macrophage colony-stimulating factor in patients with metastatic melanoma. Clin Cancer Res 1996; 2:295-302; PMID:9816172
   PubMed Web of Science ®Google Scholar
• Mizutani K, Takeuchi S, Ohashi Y, Yakushiji M, Nishimura H, Takahashi T, Maruhashi T, Ueda K, Noda K, Watanabe Y et al. Clinical usefulness of macrophage colony-stimulating factor for ovarian cancers: Long-term prognosis after five years. Oncol Rep 2003; 10:127-31; PMID:12469157
   PubMed Web of Science ®Google Scholar
• Pyonteck SM, Akkari L, Schuhmacher AJ, Bowman RL, Sevenich L, Quail DF, Olson OC, Quick ML, Huse JT, Teijeiro V et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med 2013; 19:1264-72; PMID:24056773; http://dx.doi.org/10.1038/nm.3337
   PubMed Web of Science ®Google Scholar
• Strachan DC, Ruffell B, Oei Y, Bissell MJ, Coussens LM, Pryer N, Daniel D. CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8 T cells. Oncoimmunology 2013; 2:e26968; PMID:24498562; http://dx.doi.org/10.4161/onci.26968
   PubMed Web of Science ®Google Scholar
• Casbon AJ, Lohela M, Werb Z. Delineating CSF-1-dependent regulation of myeloid cell diversity in tumors. Oncoimmunology 2015; 4:e1008871; PMID:26155427; http://dx.doi.org/10.1080/2162402X.2015.1008871
   PubMed Web of Science ®Google Scholar
• Ning Y, Lenz HJ. Targeting IL-8 in colorectal cancer. Expert Opin Ther Targets 2012; 16:491-7; PMID:22494524; http://dx.doi.org/10.1517/14728222.2012.677440
   PubMed Web of Science ®Google Scholar
• Lee YS, Choi I, Ning Y, Kim NY, Khatchadourian V, Yang D, Chung HK, Choi D, LaBonte MJ, Ladner RD et al. Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis. Br J Cancer 2012; 106:1833-41; PMID:22617157; http://dx.doi.org/10.1038/bjc.2012.177
   PubMed Web of Science ®Google Scholar
• Lin EY, Nguyen AV, Russell RG, Pollard JW. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 2001; 193:727-40; PMID:11257139; http://dx.doi.org/10.1084/jem.193.6.727
   PubMed Web of Science ®Google Scholar
• Lin EY, Gouon-Evans V, Nguyen AV, Pollard JW. The macrophage growth factor CSF-1 in mammary gland development and tumor progression. J Mammary Gland Biol Neoplasia 2002; 7:147-62; PMID:12465600; http://dx.doi.org/10.1023/A:1020399802795
   PubMed Web of Science ®Google Scholar
• Chockalingam S, Ghosh SS. Macrophage colony-stimulating factor and cancer: a review. Tumour Biol 2014; 35:10635-44; PMID:25238879; http://dx.doi.org/10.1007/s13277-014-2627-0
   PubMed Web of Science ®Google Scholar
• Grugan KD, McCabe FL, Kinder M, Greenplate AR, Harman BC, Ekert JE, van Rooijen N, Anderson GM, Nemeth JA, Strohl WR et al. Tumor-associated macrophages promote invasion while retaining Fc-dependent anti-tumor function. J Immunol 2012; 189:5457-66; PMID:23105143; http://dx.doi.org/10.4049/jimmunol.1201889
   PubMed Web of Science ®Google Scholar
• Sanda MG, Bolton E, Mule JJ, Rosenberg SA. In vivo administration of recombinant macrophage colony-stimulating factor induces macrophage-mediated antibody-dependent cytotoxicity of tumor cells. J Immunother 1992; 12:132-7; PMID:1504054; http://dx.doi.org/10.1097/00002371-199208000-00008
   PubMed Web of Science ®Google Scholar
• Munn DH, Garnick MB, Cheung NK. Effects of parenteral recombinant human macrophage colony-stimulating factor on monocyte number, phenotype, and antitumor cytotoxicity in nonhuman primates. Blood 1990; 75:2042-8; PMID:2186820
   PubMed Web of Science ®Google Scholar
• Belluco C, Nitti D, Frantz M, Toppan P, Basso D, Plebani M, Lise M, Jessup JM. Interleukin-6 blood level is associated with circulating carcinoembryonic antigen and prognosis in patients with colorectal cancer. Ann Surg Oncol 2000; 7:133-8; PMID:10761792; http://dx.doi.org/10.1007/s10434-000-0133-7
   PubMed Web of Science ®Google Scholar
• Jedinak A, Dudhgaonkar S, Sliva D. Activated macrophages induce metastatic behavior of colon cancer cells. Immunobiology 2010; 215:242-9; PMID:19457576; http://dx.doi.org/10.1016/j.imbio.2009.03.004
   PubMed Web of Science ®Google Scholar
• De Simone V, Pallone F, Monteleone G, Stolfi C. Role of T17 cytokines in the control of colorectal cancer. Oncoimmunology 2013; 2:e26617; PMID:24498548; http://dx.doi.org/10.4161/onci.26617
   PubMedGoogle Scholar
• Rakhesh M, Cate M, Vijay R, Shrikant A, Shanjana A. A TLR4-interacting peptide inhibits lipopolysaccharide-stimulated inflammatory responses, migration and invasion of colon cancer SW480 cells. Oncoimmunology 2012; 1:1495-506; PMID:23264896; http://dx.doi.org/10.4161/onci.22089
   PubMed Web of Science ®Google Scholar
• Varney ML, Olsen KJ, Mosley RL, Bucana CD, Talmadge JE, Singh RK. Monocyte/macrophage recruitment, activation and differentiation modulate interleukin-8 production: a paracrine role of tumor-associated macrophages in tumor angiogenesis. In Vivo 2002; 16:471-7; PMID:12494891
   PubMed Web of Science ®Google Scholar
• Hashimoto S, Yoda M, Yamada M, Yanai N, Kawashima T, Motoyoshi K. Macrophage colony-stimulating factor induces interleukin-8 production in human monocytes. Exp Hematol 1996; 24:123-8; PMID:8641333
   PubMed Web of Science ®Google Scholar
• Mellor H, Parker PJ. The extended protein kinase C superfamily. Biochem J 1998; 332 (Pt 2):281-92; PMID:9601053; http://dx.doi.org/10.1042/bj3320281
   PubMed Web of Science ®Google Scholar
• Wen Z, Liu H, Li M, Li B, Gao W, Shao Q, Fan B, Zhao F, Wang Q, Xie Q et al. Increased metabolites of 5-lipoxygenase from hypoxic ovarian cancer cells promote tumor-associated macrophage infiltration. Oncogene 2015; 34:1241-52; PMID:24662827; http://dx.doi.org/10.1038/onc.2014.85
   PubMed Web of Science ®Google Scholar
• Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 1998; 58:5071-4; PMID:9823313
   PubMed Web of Science ®Google Scholar
• Zhao P, Gao D, Wang Q, Song B, Shao Q, Sun J, Ji C, Li X, Li P, Qu X. Response gene to complement 32 (RGC-32) expression on M2-polarized and tumor-associated macrophages is M-CSF-dependent and enhanced by tumor-derived IL-4. Cell Mol Immunol 2015; 12:692-9; PMID:24662827; http://dx.doi.org/10.1038/cmi.2014.108.
   Web of Science ®Google Scholar